Get started
Author

Azara Janmohamed

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 2,170
PDF
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 566
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 512
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 402
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 361
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 303
Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome
1997 · Colin T. Dolphin, Azara Janmohamed, et al. · Nature Genetics · 286
Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters
2004 · Diana Hernandez, Azara Janmohamed, et al. · Pharmacogenetics · 176
The Flavin-containing Monooxygenase 2 Gene (FMO2) of Humans, but Not of Other Primates, Encodes a Truncated, Nonfunctional Protein
1998 · Colin T. Dolphin, Daniel J. Beckett, et al. · Journal of Biological Chemistry · 142
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 141
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
2023 · David E. Kandzari, Raymond R. Townsend, et al. · Journal of the American College of Cardiology · 131
Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450 2 2Abbreviations: FMO, flavin-containing monooxygenase; CYP, cytochrome P450; KGM, keratinocyte growth medium; DMEM, Dulbecco’s modified Eagle’s medium.
2001 · Azara Janmohamed, Colin T Dolphin, et al. · Biochemical Pharmacology · 125
Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos)
2004 · Azara Janmohamed, Diana Hernandez, et al. · Biochemical Pharmacology · 122
Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome
2000 · Colin T. Dolphin, Azara Janmohamed, et al. · Pharmacogenetics · 64
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
2021 · Emma Forton Magavern, Juan Carlos Kaski, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 55
PDF
Functional convergence of signalling by GPI-anchored and anchorless forms of a salamander protein implicated in limb regeneration
2010 · Robert A. Blassberg, Acely Garza-Garcia, et al. · Journal of Cell Science · 52
PDF
The phenotype of a flavin-containing monooyxgenase knockout mouse implicates the drug-metabolizing enzyme FMO1 as a novel regulator of energy balance
2014 · Sunil Veeravalli, Bilal A. Omar, et al. · Biochemical Pharmacology · 47
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 45
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 42
PDF
A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy
2000 · Helena C. Murphy, Colin T. Dolphin, et al. · Pharmacogenetics · 41
The Interface of Therapeutics and Genomics in Cardiovascular Medicine
2021 · E. F. Magavern, J. C. Kaski, et al. · Cardiovascular Drugs and Therapy · 24
PDF
Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine
2009 · Diana Hernandez, Azara Janmohamed, et al. · Pharmacogenetics and Genomics · 23
Longitudinal comparisons of mental health, burnout and well-being in patient-facing, non-patient-facing healthcare professionals and non-healthcare professionals during the COVID-19 pandemic: findings from the CoPE-HCP study
2022 · Vikas Kapil, George Collett, et al. · BJPsych Open · 21
PDF
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
2021 · Emma F Magavern, Juan Carlos Kaski, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 17
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 15
PDF
Works count: 43
Citation count: 6,015
H-index: 23
I10-index: 29
Year
Topic
Type